除中央型和骨膜型软骨肉瘤及内生软骨瘤外，其他软骨肿瘤中未发现异柠檬酸脱氢酶1（IDH1）突变。 - Suppr

IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.

作者信息

Damato Stephen, Alorjani Mohammed, Bonar Fiona, McCarthy Stanley W, Cannon Stephen R, O'Donnell Paul, Tirabosco Roberto, Amary M Fernanda, Flanagan Adrienne M

出版信息

Histopathology. 2012 Jan;60(2):363-5. doi: 10.1111/j.1365-2559.2011.04010.x. Epub 2011 Nov 10.

DOI:10.1111/j.1365-2559.2011.04010.x

PMID:22074484

Abstract

摘要

相似文献

IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.

Histopathology. 2012 Jan;60(2):363-5. doi: 10.1111/j.1365-2559.2011.04010.x. Epub 2011 Nov 10.

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.

J Pathol. 2011 Jul;224(3):334-43. doi: 10.1002/path.2913. Epub 2011 May 19.

Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.

J Pathol. 2002 Feb;196(2):194-203. doi: 10.1002/path.1023.

Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.

Virchows Arch. 2020 Jan;476(1):135-146. doi: 10.1007/s00428-019-02699-2. Epub 2019 Nov 14.

Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.

J Pathol. 2004 Mar;202(3):359-66. doi: 10.1002/path.1517.

Synovial chondrosarcoma: a single-institution experience with molecular investigations and review of the literature.

Histopathology. 2020 Sep;77(3):391-401. doi: 10.1111/his.14170. Epub 2020 Jul 28.

Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.

Cancer. 1998 Feb 1;82(3):474-83.

Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.

Am J Surg Pathol. 2009 Jan;33(1):50-7. doi: 10.1097/PAS.0b013e31817eec2b.

Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas.

Virchows Arch. 2015 Feb;466(2):217-22. doi: 10.1007/s00428-014-1685-4. Epub 2014 Nov 29.

Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.

Hum Pathol. 2017 Jul;65:239-246. doi: 10.1016/j.humpath.2017.05.015. Epub 2017 May 25.

引用本文的文献

Discovery of novel -R132C inhibitors through structure-based virtual screening.

Front Pharmacol. 2022 Sep 7;13:982375. doi: 10.3389/fphar.2022.982375. eCollection 2022.

The presence of TIM-3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status.

Brain Pathol. 2021 May;31(3):e12921. doi: 10.1111/bpa.12921. Epub 2021 Feb 12.

[Cartilage tumors: morphology, genetics, and current aspects of target therapy].

Pathologe. 2020 Mar;41(2):143-152. doi: 10.1007/s00292-020-00752-5.

Soft Tissue Special Issue: Chondroid Neoplasms of the Skull.

Head Neck Pathol. 2020 Mar;14(1):83-96. doi: 10.1007/s12105-019-01091-5. Epub 2020 Jan 16.

Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis.

Histopathology. 2019 Dec;75(6):843-852. doi: 10.1111/his.13952. Epub 2019 Sep 13.

Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.

Mod Pathol. 2019 Dec;32(12):1762-1771. doi: 10.1038/s41379-019-0315-8. Epub 2019 Jul 4.

IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis.

Virchows Arch. 2019 Nov;475(5):625-636. doi: 10.1007/s00428-019-02606-9. Epub 2019 Jun 25.

Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes.

Clin Sarcoma Res. 2019 May 28;9:9. doi: 10.1186/s13569-019-0119-0. eCollection 2019.

Epigenetics as a New Frontier in Orthopedic Regenerative Medicine and Oncology.

J Orthop Res. 2019 Jul;37(7):1465-1474. doi: 10.1002/jor.24305. Epub 2019 Apr 25.

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway.

J Bone Oncol. 2019 Jan 29;15:100222. doi: 10.1016/j.jbo.2019.100222. eCollection 2019 Apr.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献